Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Brown vs TPL-alton
2
Jun 25, 2013 07:27PM

Jun 26, 2013 02:26AM

TPL is PTSC's partner, anything effecting TPL financially could be important to PTSC. (in my opinion). From pg. 32 of the most recent 10Q

We May Be Required To Fund Our Joint Venture’s Legal Costs.

On March 20, 2013 TPL filed a petition under Chapter 11 of the United States Bankruptcy Code. While TPL’s petition does not affect the licensing agreement between PDS and Alliacense, PDS has incurred increased third-party legal costs as the litigation with HTC Corporation, and Acer, Inc., in the U.S. District Court, and the actions with the ITC Investigation No. 337-TA-853 progress. If PDS does not receive sufficient licensing revenues to pay these expenses, we may be required to pay these expenses. In the event the cost of the U.S. District Court and ITC Investigation actions exceeds our ability to fund these efforts, our options for additional sources of financing may be limited.

7
Jun 26, 2013 11:57AM

Jun 26, 2013 03:21PM
Share
New Message
Please login to post a reply